<DOC>
	<DOCNO>NCT00006366</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . Drugs use chemotherapy use different way stop tumor cell divide stop grow die . It yet know regimen radiation therapy plus chemotherapy effective rectal cancer . PURPOSE : Randomized phase II trial compare two regimen radiation therapy plus chemotherapy follow surgery treating patient locally advanced cancer rectum .</brief_summary>
	<brief_title>Radiation Therapy Plus Chemotherapy Followed Surgery Treating Patients With Locally Advanced Cancer Rectum</brief_title>
	<detailed_description>OBJECTIVES : - Compare pathological complete response , acute late normal tissue morbidity , pattern failure , complete resection rate patient locally advance adenocarcinoma distal rectum treat neoadjuvant chemoradiotherapy comprise hyperfractionated radiotherapy fluorouracil vs conventional radiotherapy , fluorouracil , irinotecan , follow radical resection . OUTLINE : This randomize study . Patients stratify accord clinical stage ( T3 v T4 ) . Patients randomize 1 2 treatment arm . - Arm I : Patients receive hyperfractionated radiotherapy ( RT ) twice daily , 5 day week 19 day . Patients receive fluorouracil IV continuously 7 day week concurrently RT . Patients clinical stage T3 fix T4 disease also receive high boost dose RT tumor . - Arm II : Patients receive conventional RT daily , 5 day week 25 day . Patients receive fluorouracil IV continuously 5 day week concurrently RT . Patients receive irinotecan IV 1 hour ( immediately prior RT dose ) weekly 4 week . Patients clinical stage T3 fix T4 disease also receive low boost dose RT tumor . Within 4-10 week completion chemoradiotherapy , patient arm undergo radical anterior resection radical abdominal perineal resection preferably total mesorectal resection . Patients follow every 3 month 2 year , every 6 month 3 year , annually thereafter . PROJECTED ACCRUAL : A total 100 patient ( 50 per arm ) accrue study within 18 month .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm adenocarcinoma distal rectum Located 09 cm dentate line ( 312 cm anal verge ) No extension malignant disease anal canal Lesions may mobile stage T3 endorectal ultrasound OR fix , define clinical stage T4 , palpation No evidence distant metastases PATIENT CHARACTERISTICS : Age : Over 18 Performance status : Zubrod 01 Life expectancy : Not specify Hematopoietic : WBC ( white blood cell count ) great 4,000/mm^3 Platelet count great 130,000/mm^3 Hepatic : Bilirubin great 1.5 time upper limit normal Alkaline phosphatase , SGOT ( serum glutamic oxaloacetic transaminase ) , LDH ( lactate dehydrogenase ) normal Renal : Creatinine normal Other : Not pregnant nursing Fertile patient must use effective contraception No invasive malignancy within past 5 year except : Inactive nonmelanomatous skin cancer Carcinoma situ cervix Synchronous colonic cancer tumor Tis T1 completely resect No serious medical illness PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy Endocrine therapy : Not specify Radiotherapy : No prior radiotherapy pelvis Surgery : Not specify Other : No concurrent antiepileptic drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2002</verification_date>
	<keyword>stage II rectal cancer</keyword>
	<keyword>stage III rectal cancer</keyword>
	<keyword>adenocarcinoma rectum</keyword>
</DOC>